PubRank
Search
About
Claes Wahlestedt
Author PubWeight™ 148.07
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Genome-wide analysis of mammalian promoter architecture and evolution.
Nat Genet
2006
17.19
2
The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line.
Nat Genet
2009
6.02
3
Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase.
Nat Med
2008
5.62
4
Myogenic gene expression signature establishes that brown and white adipocytes originate from distinct cell lineages.
Proc Natl Acad Sci U S A
2007
4.69
5
Regulatory roles of natural antisense transcripts.
Nat Rev Mol Cell Biol
2009
4.48
6
Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model.
Proc Natl Acad Sci U S A
2002
4.20
7
Complex Loci in human and mouse genomes.
PLoS Genet
2006
3.74
8
The reality of pervasive transcription.
PLoS Biol
2011
3.41
9
Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation.
Nat Biotechnol
2012
3.07
10
RNAdb--a comprehensive mammalian noncoding RNA database.
Nucleic Acids Res
2005
2.84
11
Using molecular classification to predict gains in maximal aerobic capacity following endurance exercise training in humans.
J Appl Physiol (1985)
2010
2.74
12
Striatal microRNA controls cocaine intake through CREB signalling.
Nature
2010
2.56
13
A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites.
Nucleic Acids Res
2005
2.27
14
Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality.
Nucleic Acids Res
2005
2.20
15
Evidence for natural antisense transcript-mediated inhibition of microRNA function.
Genome Biol
2010
2.08
16
MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction.
Proc Natl Acad Sci U S A
2009
2.00
17
Considerations when using the significance analysis of microarrays (SAM) algorithm.
BMC Bioinformatics
2005
1.89
18
Human muscle gene expression responses to endurance training provide a novel perspective on Duchenne muscular dystrophy.
FASEB J
2005
1.85
19
A small molecule enhances RNA interference and promotes microRNA processing.
Nat Biotechnol
2008
1.80
20
Amygdala-dependent fear is regulated by Oprl1 in mice and humans with PTSD.
Sci Transl Med
2013
1.74
21
Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes.
Genome Med
2010
1.64
22
Improved and automated prediction of effective siRNA.
Biochem Biophys Res Commun
2004
1.58
23
A novel RNA transcript with antiapoptotic function is silenced in fragile X syndrome.
PLoS One
2008
1.57
24
MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function.
Proc Natl Acad Sci U S A
2012
1.49
25
Pseudo-messenger RNA: phantoms of the transcriptome.
PLoS Genet
2006
1.46
26
Regulation of chromatin structure by long noncoding RNAs: focus on natural antisense transcripts.
Trends Genet
2012
1.46
27
Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish caucasians.
Diabetes
2004
1.41
28
MicroRNA dysregulation in psychiatric disease.
Brain Res
2010
1.34
29
Apoptosis resistance downstream of eIF4E: posttranscriptional activation of an anti-apoptotic transcript carrying a consensus hairpin structure.
Nucleic Acids Res
2006
1.27
30
Noncoding RNAs: couplers of analog and digital information in nervous system function?
Trends Neurosci
2007
1.27
31
Intronic RNAs constitute the major fraction of the non-coding RNA in mammalian cells.
BMC Genomics
2012
1.26
32
RNA interference is not involved in natural antisense mediated regulation of gene expression in mammals.
Genome Biol
2006
1.21
33
Altered regulation of the PINK1 locus: a link between type 2 diabetes and neurodegeneration?
FASEB J
2007
1.19
34
Expression profiling following local muscle inactivity in humans provides new perspective on diabetes-related genes.
Genomics
2005
1.18
35
microRNAs in CNS disorders.
Neuromolecular Med
2009
1.17
36
Analysis of siRNA specificity on targets with double-nucleotide mismatches.
Nucleic Acids Res
2008
1.14
37
Validating siRNA using a reporter made from synthetic DNA oligonucleotides.
Biochem Biophys Res Commun
2004
1.14
38
Therapeutic potential of neuropeptide Y (NPY) receptor ligands.
EMBO Mol Med
2010
1.12
39
NotI subtraction and NotI-specific microarrays to detect copy number and methylation changes in whole genomes.
Proc Natl Acad Sci U S A
2002
1.10
40
Small GTP-binding protein Rac is an essential mediator of vascular endothelial growth factor-induced endothelial fenestrations and vascular permeability.
Circulation
2003
1.10
41
The human PINK1 locus is regulated in vivo by a non-coding natural antisense RNA during modulation of mitochondrial function.
BMC Genomics
2007
1.10
42
Personalized medicine in psychiatry: problems and promises.
BMC Med
2013
1.09
43
Activity-induced and developmental downregulation of the Nogo receptor.
Cell Tissue Res
2003
1.07
44
Kinetics of senescence-associated changes of gene expression in an epithelial, temperature-sensitive SV40 large T antigen model.
Cancer Res
2004
1.07
45
Identification of functional SNPs in the 5-prime flanking sequences of human genes.
BMC Genomics
2005
1.07
46
Effective small interfering RNAs and phosphorothioate antisense DNAs have different preferences for target sites in the luciferase mRNAs.
Biochem Biophys Res Commun
2003
1.06
47
A new approach to genome mapping and sequencing: slalom libraries.
Nucleic Acids Res
2002
1.05
48
Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism.
J Psychiatr Res
2004
1.04
49
Involvement of long noncoding RNAs in diseases affecting the central nervous system.
RNA Biol
2012
1.04
50
The expression signature of in vitro senescence resembles mouse but not human aging.
Genome Biol
2005
1.03
51
Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression.
Blood
2013
1.03
52
Comprehensive analysis of the transcriptional landscape of the human FMR1 gene reveals two new long noncoding RNAs differentially expressed in Fragile X syndrome and Fragile X-associated tremor/ataxia syndrome.
Hum Genet
2013
1.01
53
Selective and brain penetrant neuropeptide y y2 receptor antagonists discovered by whole-cell high-throughput screening.
Mol Pharmacol
2009
0.98
54
Non-coding RNA transcripts: sensors of neuronal stress, modulators of synaptic plasticity, and agents of change in the onset of Alzheimer's disease.
Neurosci Lett
2009
0.96
55
hUNC93B1: a novel human gene representing a new gene family and encoding an unc-93-like protein.
Gene
2002
0.96
56
Epigenetic mechanisms of gene regulation during mammalian spermatogenesis.
Epigenetics
2008
0.95
57
Human neuropeptide Y signal peptide gain-of-function polymorphism is associated with increased body mass index: possible mode of function.
Regul Pept
2005
0.93
58
RNA Interference with chemically modified siRNA.
Curr Top Med Chem
2006
0.93
59
No induction of anti-viral responses in human cell lines HeLa and MCF-7 when transfecting with siRNA or siLNA.
Biochem Biophys Res Commun
2006
0.93
60
Locked nucleic acid containing antisense oligonucleotides enhance inhibition of HIV-1 genome dimerization and inhibit virus replication.
FEBS Lett
2004
0.92
61
NotI flanking sequences: a tool for gene discovery and verification of the human genome.
Nucleic Acids Res
2002
0.92
62
GeneLynx mouse: integrated portal to the mouse genome.
Genome Res
2003
0.92
63
Association between the nociceptin receptor gene (OPRL1) single nucleotide polymorphisms and alcohol dependence.
Addict Biol
2008
0.91
64
A novel single nucleotide polymorphism of the neuropeptide Y (NPY) gene associated with alcohol dependence.
Alcohol Clin Exp Res
2005
0.91
65
NPY Leu7Pro and alcohol dependence in Finnish and Swedish populations.
Alcohol Clin Exp Res
2003
0.90
66
Functional comparison of single- and double-stranded siRNAs in mammalian cells.
Biochem Biophys Res Commun
2004
0.90
67
mRNA accessible site tagging (MAST): a novel high throughput method for selecting effective antisense oligonucleotides.
Nucleic Acids Res
2003
0.90
68
Knockdown of BACE1-AS Nonprotein-Coding Transcript Modulates Beta-Amyloid-Related Hippocampal Neurogenesis.
Int J Alzheimers Dis
2011
0.90
69
The BET-Bromodomain Inhibitor JQ1 Reduces Inflammation and Tau Phosphorylation at Ser396 in the Brain of the 3xTg Model of Alzheimer's Disease.
Curr Alzheimer Res
2016
0.89
70
The Emerging Role of Non-Coding RNAs in Drug Addiction.
Front Genet
2012
0.89
71
A universal plasmid library encoding all permutations of small interfering RNA.
Proc Natl Acad Sci U S A
2005
0.89
72
Complex HTR2C linkage disequilibrium and promoter associations with body mass index and serum leptin.
Hum Genet
2005
0.89
73
Genetics of neurological disorders.
Expert Rev Mol Diagn
2004
0.88
74
RNAi screen indicates widespread biological function for human natural antisense transcripts.
PLoS One
2010
0.86
75
Gene characterization index: assessing the depth of gene annotation.
PLoS One
2008
0.86
76
Role of Sirtuin 1 in metabolic regulation.
Drug Discov Today
2010
0.85
77
Characterization of RNA interference in rat PC12 cells: requirement of GERp95.
Biochem Biophys Res Commun
2004
0.85
78
Epigenetic pathways and glioblastoma treatment.
Epigenetics
2013
0.85
79
Behavioural analysis of melanin-concentrating hormone in rats: evidence for orexigenic and anxiolytic properties.
Regul Pept
2003
0.84
80
Adult neurogenesis: a potential tool for early diagnosis in Alzheimer's disease?
J Alzheimers Dis
2010
0.83
81
Focusing on RISC assembly in mammalian cells.
Biochem Biophys Res Commun
2008
0.83
82
Nonsynonymous SNPs: validation characteristics, derived allele frequency patterns, and suggestive evidence for natural selection.
Hum Mutat
2006
0.82
83
Navigating genomic maps of cancer cells.
Nat Biotechnol
2010
0.82
84
Transcriptional repression of ER through hMAPK dependent histone deacetylation by class I HDACs.
Breast Cancer Res Treat
2014
0.80
85
Functional interactions between delta- and mu-opioid receptors in rat thermoregulation.
Eur J Pharmacol
2003
0.79
86
Anti-cataleptic effects of clozapine, but not olanzapine and quetiapine, on SCH 23390- or raclopride-induced catalepsy in rats.
Eur Neuropsychopharmacol
2003
0.79
87
Quantitative codon optimisation of DNA libraries encoding sub-random peptides: design and characterisation of a novel library encoding transmembrane domain peptides.
Nucleic Acids Res
2002
0.78
88
Synthesis and SAR of selective small molecule neuropeptide Y Y2 receptor antagonists.
Bioorg Med Chem Lett
2012
0.77
89
Vector-based siRNA delivery strategies for high-throughput screening of novel target genes.
J RNAi Gene Silencing
2005
0.76
90
Analysis of 5-hydroxytryptamine 2c receptor gene promoter variants as alcohol-dependence risk factors.
Alcohol Alcohol
2004
0.76
91
Oligonucleotides for upregulating gene expression.
Pharm Pat Anal
2013
0.76
92
Extracellular Uridine Triphosphate and Adenosine Triphosphate Attenuate Endothelial Inflammation through miR-22-Mediated ICAM-1 Inhibition.
J Vasc Res
2015
0.76
93
RNA mechanisms in CNS systems and disorders.
Brain Res
2010
0.75
94
RNAi joins the "Singles Club".
Mol Ther
2012
0.75
95
Exploring the foundation of genomics: a northern blot reference set for the comparative analysis of transcript profiling technologies.
Comp Funct Genomics
2004
0.75
96
How the strengths of Lisp-family languages facilitate building complex and flexible bioinformatics applications.
Brief Bioinform
2016
0.75
97
Antisense-induced Fas mRNA degradation produces site-specific stable 3'-mRNA fragment by exonuclease cleavage at the complementary sequence.
Oligonucleotides
2004
0.75
98
How the strengths of Lisp-family languages facilitate building complex and flexible bioinformatics applications.
Brief Bioinform
2017
0.75